Jordan Alana Ciuro, MD, assistant professor of medicine at Winship Cancer Institute at Emory University, shares key abstracts and topics from the upcoming 2025 ASCO GU Symposium. Dr. Ciuro highlights the latest research in biomarker-driven oncology, prostate cancer treatment advancements, kidney cancer disparities, and emerging therapies in bladder cancer. Key trials, including TALAPRO-2, COSMIC-313, and EV-302, are explored, along with insights into antibody-drug conjugates and their evolving role in GU cancers.
- Category
- Oncology

Be the first to comment